2.2. Synthesis of Oxetane Derivatives

MK Mateusz Korzec
DT Daiva Tavgeniene
NS Nizy Sara Samuel
RB Raminta Beresneviciute
GK Gintare Krucaite
AP Agnieszka Katarzyna Pająk
SK Sonia Kotowicz
MV Marharyta Vasylieva
PG Paweł Gnida
JM Jan Grzegorz Malecki
SG Saulius Grigalevicius
ES Ewa Schab-Balcerzak
ask Ask a question
Favorite

3,3-Di[3-iodocarbazol-9-ylmethyl]oxetane (3) was synthesized and characterized according to the procedure described in the literature [15].

3,3-Di[3-(1-naphthyl)carbazol-9-ylmethyl]oxetane (4). 0.4 g (0.6 mmol) of 3,3-di[3-iodocarbazol-9-yl]methyloxetane (3), 0.26 g (1.5 mmol) of naphthalene-1-boronic acid, 0.02 g (0.03 mmol) of PdCl2(PPh3)2 and 0.17 g (3.0 mmol) of powdered KOH were stirred in 8 mL of THF containing degassed water (1 mL) at 80 °C under nitrogen for 1.5 h. After TLC control the reaction mixture was cooled and quenched by the addition of ice water. The product was extracted with chloroform. The combined extract was dried over anhydrous Na2SO4. The crude product was purified by silica gel column chromatography using the mixture of ethyl acetate and hexane (vol. ratio 1:7) as an eluent. Yield: 0.3 g of white crystals (75%). DSC: Tm = 250 °C. MS (APCI+, 20 V): 669.49 ([M+H], 100%). 1H NMR (400 MHz, CDCl3, δ:ppm): 8.21–8.04 (m, 4H, Ar), 7.93–7.79 (m, 6H, Ar), 7.56–7.28 (m, 16H, Ar), 7.26–7.20 (m, 2H, Ar), 4.75 (s, 4H, 2×OCH2), 4.72 (s, 4H, 2×NCH2). 13C NMR (100 MHz, CDCl3, δ:ppm): 141.90, 140.85, 140.65, 133.90, 132.52, 132.15, 128.38, 128.30, 127.41, 126.38, 126.28, 126.04, 125.76, 125.45, 123.46, 123.41, 122.09, 120.79, 119.98, 108.876, 108.44, 76.12, 50.79, 47.64. FT-IR (KBr), cm−1: 3051, 2954, 2923, 2853, 1941, 1733, 1623, 1600, 1572, 1535, 1490, 1465, 1394, 1330, 1290, 1264, 1226, 1156, 986, 968, 800, 776, 745.

3,3-Di[3-(9-ethylcarbazol-3-yl)carbazol-9-ylmethyl]oxetane (5). 0.4 g (0.6 mmol) of 3,3-di[3-iodocarbazol-9-yl]methyloxetane (3), 0.48 g (1.5 mmol) of 9-ethyl-9H-carbazole-3-boronic acid pinacol ester, 0.02 g (0.03 mmol) of PdCl2(PPh3)2 and 0.17 g (3.0 mmol) of powdered KOH were stirred in 8 mL of THF containing degassed water (1 mL) at 80 °C under nitrogen for 2 h. After TLC control the reaction mixture was cooled and quenched by the addition of ice water. The product was extracted with chloroform. The combined extract was dried over anhydrous Na2SO4. The crude product was purified by silica gel column chromatography using the mixture of ethyl acetate and hexane (vol. ratio 1:5) as an eluent. Yield: 0.25 g of white amorphous product (52%). MS (APCI+, 20 V): 803.58 ([M+H], 100%). 1H NMR (400 MHz, CDCl3, δ:ppm): 8.31–8.09 (m, 6H, Ar), 7.47–7.34 (m, 10H, Ar), 7.31–7.12 (m, 10H, Ar), 4.65 (s, 4H, 2×OCH2), 4.64 (s, 4H, 2×NCH2), 4.37–4.26 (m, 4H, 2×NCH2CH3), 1.38 (t, 6H, J = 6.8 Hz, 2×CH3). 13C NMR (100 MHz, CDCl3, δ:ppm): 141.90, 140.50, 140.44, 139.16, 134.44, 132.97, 126.24, 126.04, 125.78, 125.53, 123.95, 123.59, 123.57, 123.15, 120.77, 120.57, 119.80, 119.20, 119.09, 118.87, 108.99, 108.86, 108.73, 108.60, 76.07, 50.825, 47.52, 37.68, 13.90. FT-IR (KBr), cm−1: 3048, 2967, 2928, 2870, 1877, 1731, 1627, 1600, 1472, 1456, 1380, 1330, 1231, 1154, 1124, 1088, 1065, 1024, 969, 878, 798, 781, 745, 727.

3,3-Di[3-(4-(diphenylamino)phenyl)carbazol-9-ylmethyl]oxetane (6). 0.4 g (0.6 mmol) of 3,3-di[3-iodocarbazol-9-yl]methyloxetane (3), 0.43 g (1.5 mmol) of 4-(diphenylamino)phenylboronic acid, 0.02 g (0.03 mmol) of PdCl2(PPh3)2 and 0.17 g (3.0 mmol) of powdered KOH were stirred in 8 mL of THF containing degassed water (1 mL) at 80 °C under nitrogen for 1.5 h. After TLC control the reaction mixture was cooled and quenched by the addition of ice water. The product was extracted with chloroform. The combined extract was dried over anhydrous Na2SO4. The crude product was purified by silica gel column chromatography using the mixture of ethyl acetate and hexane (vol. ratio 1:7) as an eluent. Yield: 0.3 g of white amorphous product (56%). MS (APCI+, 20 V): 903.56 ([M+H], 100%). 1H NMR (400 MHz, CDCl3, δ:ppm): 8.24–8.06 (m, 6H, Ar), 7.63–7.55 (m, 2H, Ar), 7.51–7.33 (m, 7H, Ar), 7.29–7.19 (m, 12H, Ar), 7.14–7.03 (m, 12H, Ar), 6.99–6.90 (m, 5H, Ar), 4.65 (s, 4H, 2×OCH2), 4.61 (s, 4H, 2×NCH2). 13C NMR (100 MHz, CDCl3, δ:ppm): 147.82, 146.65, 141.86, 140.66, 135.95, 132.89, 129.30, 127.95, 126.32, 125.33, 124.41, 124.28, 123.87, 123.48, 122.807, 120.71, 119.90, 118.66, 108.96, 108.85, 75.99, 50.77, 47.49. FT-IR (KBr), cm−1: 3055, 3031, 2954, 2923, 2866, 1965, 1625, 1589, 1515, 1488, 1451, 1384, 1331, 1275, 1230, 1178, 1155, 1073, 1028, 969, 889, 803, 748, 696.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A